(Q34520874)

English

Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center (English)

1 reference

Europe PubMed Central

2 August 2017

0 references

piperacillin/tazobactam

1 reference

based on heuristic

inferred from title

author name string

Flora S Siami

1

1 reference

Europe PubMed Central

2 August 2017

Bonnie J LaFleur

2

1 reference

Europe PubMed Central

2 August 2017

Ghodrat A Siami

3

1 reference

Europe PubMed Central

2 August 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

2 August 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

2 August 2017

24

1 reference

Europe PubMed Central

2 August 2017

1

1 reference

Europe PubMed Central

2 August 2017

59-72

1 reference

Europe PubMed Central

2 August 2017

Infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Current aspects of bacterial infections of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Grou

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an International Surveillance Programme. SENTRY Participants Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical aspects of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

General principles of antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial clinical experience with clinafloxacin in the treatment of serious infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mode of action of fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoroquinolone treatment of skin and skin structure infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Expanded activity and utility of the new fluoroquinolones: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional and genetic laboratory tests used to guide antimicrobial therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of fluoroquinolone resistance: an update 1994-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity of quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985005-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(02)85005-6

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34520874&oldid=1562876973"